Shan, Jianzhen
First Affiliated Hospital Zhejiang University · Zhejiang University
2 papers on CoChatORCID 0000-0001-5308-7056
Most cited papers
- Verified
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Ruan, D.-Y., Wu, H.-X., Xu, Y., Munster, P. N., Deng, Y., Richardson, G., Yan, D., Lee, M.-A., Lee, K.-W., Pan, H., et al. (2025) · Signal Transduction and Targeted Therapy
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 22
- Verified
Efficacy and safety of garsorasib in patients with KRAS G12C-mutated advanced pancreatic cancer
Yamamoto, N., Yan, D., Ganju, V., Hou, X., Pan, H., Shan, J., Wang, L., Kim, S.-W., Richardson, G., Sanborn, R. E., et al. (2026) · British Journal of Cancer
Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment
Cited by 5
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free